tiprankstipranks
Pacira (PCRX)
:PCRX
US Market
Holding PCRX?
Track your performance easily

Pacira Pharmaceuticals (PCRX) Stock Investors

356 Followers
Based on 781,107 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold PCRX
On average, investors allocate 0.00% of their portfolios to PCRX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 781,107 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding PCRX

1.9%
Last 7
Days
1.9%
Last 30
Days
Percentages indicate the change in the number of portfolios holding PCRX, out of 781,107 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

PCRX Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.03%
$20.00
Opened
2.86%
$17.13
Based on the activity of investors who made their portfolios public
The table shows changes in PCRX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

PCRX Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
4.86%
-0.16%
+3.22%
34.60B
Consumer Cyclical
Plug Power
5.13%
-0.15%
+2.45%
2.22B
Industrials
JD
4.88%
-0.26%
+2.22%
59.91B
Consumer Cyclical
CVS Health
3.89%
-0.16%
+1.54%
66.22B
Healthcare
Bristol-Myers Squibb
3.38%
+0.31%
+1.84%
114.17B
Healthcare
First Solar
4.11%
-0.50%
+1.91%
20.65B
Technology
Datadog
3.60%
-0.08%
+3.40%
47.02B
Technology
ServiceNow
3.89%
-0.22%
+2.31%
220.72B
Technology
Fortinet
3.59%
-0.74%
+5.83%
72.22B
Technology
Target
3.94%
-0.75%
-1.84%
61.22B
Consumer Defensive
Based on the activity of 781,107 active portfolios
Open your Smart Portfolio

PCRX Investor Analysis

PCRX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
18.0%
of PCRX holders
are under 35
Average Segment Performance
Average P/E Ratio31.21
Beta11.07
Dividend Yield3.84%
PCRX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
46.0%
of PCRX holders
are between 35–55
Average Segment Performance
Average P/E Ratio28.26
Beta20.30
Dividend Yield3.31%
PCRX investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
36.0%
of PCRX holders
are over 55
Average Segment Performance
Average P/E Ratio26.34
Beta10.16
Dividend Yield3.48%
Overview of age group and performance of PCRX stock investors
See who invests in PCRX according to age group and performance.

FAQ

How many retail Investors hold PCRX?
<0.1% of TipRanks' retail investors hold PCRX in their portfolios.
    What is PCRX Investor Sentiment?
    PCRX’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of PCRX in the last 7 days?
      ▼ 1.9% of TipRanks' retail investors changed their holding of PCRX in the last 7 days.
        What percentage of retail investors changed their holding of PCRX in the last 30 days?
        ▼ 1.9% of TipRanks' retail investors changed their holding of PCRX in the last 30 days.
          What is the average age of retail investors who hold PCRX?
          The average age of PCRX Holders is between 35–55.
            What other stocks have PCRX investors also bought?
            PCRX Investors also bought DKNG, PLUG, JD, CVS, BMY, FSLR, DDOG, NOW, FTNT, TGT.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              AAgilent
              ALNYAlnylam Pharma
              ANGOAngioDynamics
              BDXBecton Dickinson
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis